ProfileGDS4132 / 235927_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 28% 34% 35% 32% 29% 33% 36% 40% 34% 35% 46% 35% 35% 39% 39% 34% 41% 47% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10178.67432
GSM201543Muscle PCOS pioglitazone 12158.733728
GSM201544Muscle PCOS pioglitazone 16186.738534
GSM201545Muscle PCOS pioglitazone 20197.682635
GSM201829Muscle PCOS pioglitazone 23183.666732
GSM201830Muscle PCOS pioglitazon 25172.597329
GSM201831Muscle PCOS pioglitazone 27179.476433
GSM201832Muscle PCOS pioglitazone 3191.465436
GSM201833Muscle PCOS pioglitazone 4197.173240
GSM201834Muscle PCOS pioglitazone 8182.882434
GSM201835Muscle PCOS after pioglitazone 10274.785935
GSM201836Muscle PCOS after pioglitazone 122111.09146
GSM201837Muscle PCOS after pioglitazone 16274.801735
GSM201838Muscle PCOS after pioglitazone 20279.424235
GSM201839Muscle PCOS after pioglitazone 23293.873339
GSM201840Muscle PCOS after pioglitazone 25297.513239
GSM201841Muscle PCOS after pioglitazone 27269.978434
GSM201842Muscle PCOS after pioglitazone 3286.113241
GSM201843Muscle PCOS after pioglitazone 42118.68147
GSM201844Muscle PCOS after pioglitazone 82105.48542